Because PPARγ activation may have a dual effect on prostate cancer (21), results derived from cellular studies should be carefully interpreted and clinical trials in humans are pivotal to elucidate the roles of different TZD compounds in the development or prevention of prostate cancer. This evidence concerns the gene PPARG and Familial prostate cancer.